|
Estimating health and economic benefits from using prescription omega-3 fatty acids in patients with severe hypertriglyceridemia |
Samuel S, Peskin B, Arondekar B, Alperin P, Johnson S, Blumenfeld I, Stone G, Jacobson TA |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Samuel S, Peskin B, Arondekar B, Alperin P, Johnson S, Blumenfeld I, Stone G, Jacobson TA. Estimating health and economic benefits from using prescription omega-3 fatty acids in patients with severe hypertriglyceridemia. American Journal of Cardiology 2011; 108(5): 691-697 Indexing Status Subject indexing assigned by NLM MeSH Aged; Coronary Disease /prevention & Cost-Benefit Analysis; Diabetes Mellitus, Type 2 /complications; Fatty Acids, Omega-3 /therapeutic use; Female; Humans; Hypertriglyceridemia /drug therapy; Longitudinal Studies; Male; Middle Aged; Models, Biological; Myocardial Infarction /prevention & Quality-Adjusted Life Years; Risk Assessment; Risk Factors; control; control AccessionNumber 22012000136 Date bibliographic record published 23/01/2013 |
|
|
|